Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lung yin deficiency syndrome is a TCM diagnostic pattern that occurs when the yin aspect (moistening and cooling functional properties) of the lung is depleted[5][1][3][7]. This syndrome manifests with symptoms such as dry cough, dry throat, hoarse voice, dry nasal cavities, scanty sputum, possible hemoptysis (coughing blood), afternoon fever, warm palms and soles, emaciation, and red dry tongue with thready rapid pulse[1][5][9]. The syndrome frequently affects middle-aged and elderly individuals, and results from factors such as excessive use of voice, smoking, chronic emotional stress, or as a sequela to chronic illness[5][1][3]. Pathophysiologically, it is described in TCM as an inability of the Lung to be nourished by yin fluids, resulting in internal dryness and "empty heat"[9]. While some herbal formulas (e.g., Yang Yin Qing Fei Tang, Qing Zao Jiu Fei Tang, Bu Fei E Jiao Tang) may be prescribed to "tonify" lung yin, these are not directed at a molecular target but rather at improving the holistic yin status as conceptualized in TCM[5][2]. The pattern is sometimes associated with western medicine diagnoses such as pulmonary tuberculosis, chronic bronchitis, chronic pharyngitis, bronchiectasis, and lung adenocarcinoma, where patients present with dry pulmonary symptoms and are deemed to have yin deficiency by TCM criteria[1][8]. TCM approaches for lung yin deficiency are distinct from Western biomedicine, and do not map to a single receptor, molecule, or pathway. There is no canonical molecule, abbreviation, molecular classification, biological function, or drug interaction that applies as per biomedical target databases. Thus, for structured biomedical data, this should not be captured as a molecule/receptor therapeutic target—it is a clinical pattern, not a molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lung yin deficiency syndrome.